Propofol alternatives in gastrointestinal endoscopy anesthesia

Basavana Gouda Goudra, Preet Mohinder Singh, Basavana Gouda Goudra, Preet Mohinder Singh

Abstract

Although propofol has been the backbone for sedation in gastrointestinal endoscopy, both anesthesiologists and endoscopists are faced with situations where an alternative is needed. Recent national shortages forced many physicians to explore these options. A midazolam and fentanyl combination is the mainstay in this area. However, there are other options. The aim of this review is to explore these options. The future would be, invariably, to move away from propofol. The reason is not in any way related to the drawbacks of propofol as a sedative. The mandate that requires an anesthesia provider to administer propofol has been a setback in many countries. New sedative drugs like Remimazolam might fill this void in the future. In the meantime, it is important to keep an open eye to the existing alternatives.

Keywords: GI endoscopy sedation; non-anesthetist administered propofol; propofol Remimazolam; propofol complications in sedation.

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Porostocky P, Chiba N, Colacino P, Sadowski D, Singh H. A survey of sedation practices for colonoscopy in Canada. Can J Gastroenterol. 2011;25:255–60.
    1. Riphaus A, Macias-Gomez C, Devière J, Dumonceau JM. Propofol, the preferred sedation for screening colonoscopy, is underused. Results of an international survey. Dig Liver Dis. 2012;44:389–92.
    1. Baombe JP, Parvez K. Towards evidence-based emergency medicine: Best BETs from the Manchester Royal Infirmary. BET 1: Is propofol safe in patients with egg anaphylaxis? Emerg Med J. 2013;30:79–80.
    1. Garnock-Jones KP, Scott LJ. Fospropofol. Drugs. 2010;70:469–77.
    1. Cohen LB, Wecsler JS, Gaetano JN, Benson AA, Miller KM, Durkalski V, et al. Endoscopic sedation in the United States: Results from a nationwide survey. Am J Gastroenterol. 2006;101:967–74.
    1. Al-Qurain A. Comparative study of diazepam and midazolam for sedation during upper gastrointestinal endoscopy. Curr Ther Res. 1993;53:375–80.
    1. Koshy G, Nair S, Norkus EP, Hertan HI, Pitchumoni CS. Propofol versus midazolam and meperidine for conscious sedation in GI endoscopy. Am J Gastroenterol. 2000;95:1476–9.
    1. Paspatis GA, Manolaraki M, Xirouchakis G, Papanikolaou N, Chlouverakis G, Gritzali A. Synergistic sedation with midazolam and propofol versus midazolam and pethidine in colonoscopies: A prospective, randomized study. Am J Gastroenterol. 2002;97:1963–7.
    1. Practice guidelines for sedation and analgesia by nonanesthesiologists. Anesthesiology. 2002;96:1004–17.
    1. Goudra BG, Singh PM. Cardiac arrests during endoscopy with anesthesia assistance. JAMA Intern Med. 2013;173:1659–60.
    1. Cooper GS, Kou TD, Rex DK. Complications following colonoscopy with anesthesia Assistance-A population-based analysis complications after colonoscopy with anesthesia. JAMA Intern Med. 2013;173:551–6.
    1. Reeves ST, Havidich JE, Tobin DP. Conscious sedation of children with propofol is anything but conscious. Pediatrics. 2004;114:e74–6.
    1. Smith MR, Bell GD, Quine MA, Spencer GM, Morden AE, Jones JG. Small bolus injections of intravenous midazolam for upper gastrointestinal endoscopy: A study of 788 consecutive cases. Br J Clin Pharmacol. 1993;36:573–8.
    1. Alexander R, Fardell S. Use of remifentanil for tracheal intubation for caesarean section in a patient with suxamethonium apnoea. Anesthesia. 2005;60:1036–8.
    1. Bouvet L, Allaouchiche B, Duflo F, Debon R, Chassard D, Boselli E. Remifentanil is an effective alternative to propofol for patient-controlled analgesia during digestive endoscopic procedures. Can J Anaesth. 2004;51:122–5.
    1. Toklu S, Iyilikci L, Gonen C, Ciftci L, Gunenc F, Sahin E, et al. Comparison of etomidate-remifentanil and propofol-remifentanil sedation in patients scheduled for colonoscopy. Eur J Anaesthesiol. 2009;26:370–6.
    1. Koitabashi T, Johansen JW, Sebel PS. Remifentanil dose/electroencephalogram bispectral response during combined propofol/regional anesthesia. Anesth Analg. 2002;94:1530–3.
    1. Vennila R, Hall A, Ali M, Bhuiyan N, Pirotta D, Raw DA. Remifentanil as single agent to facilitate awake fibreoptic intubation in the absence of premedication. Anesthesia. 2011;66:368–72.
    1. Goudra BG, Singh PM, Sinha AC. Anesthesia for ERCP: Impact of anesthesiologist's experience on outcome and cost. Anesthesiol Res Pract. 2013;2013:570518.
    1. Goudra BG, Singh PM, Sinha A. Outpatient endoscopic retrograde cholangiopancreatography: Safety and efficacy of anesthetic management with a natural airway in 653 consecutive procedures. Saudi J Anaesth. 2013;3:259–65.
    1. Manolaraki MM, Theodoropoulou A, Stroumpos C, Vardas E, Oustamanolakis P, Gritzali A, et al. Remifentanil compared with midazolam and pethidine sedation during colonoscopy: A prospective, randomized study. Dig Dis Sci. 2008;53:34–40.
    1. Miqdady MI, Hayajneh WA, Abdelhadi R, Gilger MA. Ketamine and midazolam sedation for pediatric gastrointestinal endoscopy in the Arab world. World J Gastroenterol. 2011;17:3630–5.
    1. Lightdale JR, Mitchell PD, Fredette ME, Mahoney LB, Zgleszewski SE, Scharff L, et al. A pilot study of ketamine versus midazolam/fentanyl sedation in children undergoing GI endoscopy. Int J Pediatr. 2011;2011:623710.
    1. Papoff P, Mancuso M, Caresta E, Moretti C. Effectiveness and safety of propofol in newborn infants. Pediatrics. 2008;121:448.
    1. Sener S, Eken C, Schultz CH, Serinken M, Ozsarac M. Ketamine with and without midazolam for emergency department sedation in adults: A randomized controlled trial. Ann Emerg Med. 2011;57:109–14. e2.
    1. Varadarajulu S, Eloubeidi MA, Tamhane A, Wilcox CM. Prospective randomized trial evaluating ketamine for advanced endoscopic procedures in difficult to sedate patients. Aliment Pharmacol Ther. 2007;25:987–97.
    1. Green SM, Roback MG, Krauss B Emergency Department ketamine meta-analysis study group. Laryngospasm during emergency department ketamine sedation: A case-control study. Pediatr Emerg Care. 2010;26:798–802.
    1. Scheinin H, Aantaa R, Anttila M, Hakola P, Helminen A, Karhuvaara S. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha2-adrenoceptor antagonist atipamezole: A pharmacodynamic and kinetic study in healthy volunteers. Anesthesiology. 1998;89:574–84.
    1. Kaur M, Singh P. Current role of dexmedetomidine in clinical anesthesia and intensive care. Anesth Essays Res. 2011;5:128.
    1. Demiraran Y, Korkut E, Tamer A, Yorulmaz I, Kocaman B, Sezen G, et al. The comparison of dexmedetomidine and midazolam used for sedation of patients during upper endoscopy: A prospective, randomized study. Can J Gastroenterol. 2007;21:25–9.
    1. Jalowiecki P, Rudner R, Gonciarz M, Kawecki P, Petelenz M, Dziurdzik P. Sole use of dexmedetomidine has limited utility for conscious sedation during outpatient colonoscopy. Anesthesiology. 2005;103:269–73.
    1. Dere K, Sucullu I, Budak ET, Yeyen S, Filiz AI, Ozkan S, et al. A comparison of dexmedetomidine versus midazolam for sedation, pain and hemodynamic control, during colonoscopy under conscious sedation. Eur J Anaesthesiol. 2010;27:648–52.
    1. Muller S, Borowics SM, Fortis EA, Stefani LC, Soares G, Maguilnik I, et al. Clinical efficacy of dexmedetomidine alone is less than propofol for conscious sedation during ERCP. Gastrointest Endosc. 2008;67:651–9.
    1. Kilpatrick GJ, McIntyre MS, Cox RF, Stafford JA, Pacofsky GJ, Lovell GG, et al. CNS 7056: A novel ultra-short-acting Benzodiazepine. Anesthesiology. 2007;107:60–6.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir